- Home
- LFMDP vs SCLXW Comparison
LFMDP vs SCLXW Comparison
Compare LFMDP & SCLXW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFMDP
- SCLXW
- Stock Information
- Founded
- LFMDP N/A
- SCLXW N/A
- Country
- LFMDP United States
- SCLXW United States
- Employees
- LFMDP 232
- SCLXW 105
- Industry
- LFMDP Medical/Nursing Services
- SCLXW Biotechnology: Pharmaceutical Preparations
- Sector
- LFMDP Health Care
- SCLXW Health Care
- Exchange
- LFMDP Nasdaq
- SCLXW Nasdaq
- Market Cap
- LFMDP N/A
- SCLXW N/A
- IPO Year
- LFMDP N/A
- SCLXW 2021
- Fundamental
- Price
- LFMDP $22.40
- SCLXW $0.21
- Analyst Decision
- LFMDP
- SCLXW
- Analyst Count
- LFMDP 0
- SCLXW 0
- Target Price
- LFMDP N/A
- SCLXW N/A
- AVG Volume (30 Days)
- LFMDP N/A
- SCLXW N/A
- Earning Date
- LFMDP N/A
- SCLXW N/A
- Dividend Yield
- LFMDP N/A
- SCLXW N/A
- EPS Growth
- LFMDP N/A
- SCLXW N/A
- EPS
- LFMDP N/A
- SCLXW N/A
- Revenue
- LFMDP N/A
- SCLXW N/A
- Revenue This Year
- LFMDP N/A
- SCLXW N/A
- Revenue Next Year
- LFMDP N/A
- SCLXW N/A
- P/E Ratio
- LFMDP N/A
- SCLXW N/A
- Revenue Growth
- LFMDP N/A
- SCLXW N/A
- 52 Week Low
- LFMDP N/A
- SCLXW N/A
- 52 Week High
- LFMDP N/A
- SCLXW N/A
- Technical
- Relative Strength Index (RSI)
- LFMDP 52.14
- SCLXW N/A
- Support Level
- LFMDP $22.00
- SCLXW N/A
- Resistance Level
- LFMDP $23.00
- SCLXW N/A
- Average True Range (ATR)
- LFMDP 0.42
- SCLXW 0.00
- MACD
- LFMDP -0.02
- SCLXW 0.00
- Stochastic Oscillator
- LFMDP 63.81
- SCLXW 0.00
About LFMDP LifeMD Inc.
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.
About SCLXW Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.